Advertisement

PentaVision

Ophthalmic Professional

Article

Opening Lines

Ophthalmic Professional May 1, 2021 Vol 10, Issue May/June 2021 Page(s): 8

OP Co-Editor Bruce Maller to retire

Bruce Maller has announced he will retire from his job as consultant and CEO of BSM Consulting, while also stepping down from his position as co-editor-in-chief of Ophthalmic Professional, effective with the July/August issue. Judy Williams has been appointed to succeed Mr. Maller as OP’s co-editor-in-chief. Jane Shuman, COT, COE, OCS, will continue in her role as co-editor-in-chief.

Both Mr. Maller and Ms. Shuman have served as lead editors of OP since the publication’s launch in 2012. Their efforts have ensured that OP continues its mission of providing “timely, relevant, and practical business and clinical resources to make your job easier,” as Mr. Maller stated in the premier issue of OP.

“During the last 40-plus years, I don’t think there has been any one person who has impacted the practice of ophthalmology more than Bruce Maller,” says Doug Parry, publisher of OP and executive vice president ophthalmology, PentaVision. “His instincts and leadership in staff training, practice management, and the business of ophthalmology have elevated the performance of so many practices. There wouldn’t be an OP without Bruce’s model of dedication and commitment to excellence.”

Mr. Maller is the founder and CEO of BSM Consulting, an internationally recognized health care consulting firm he founded in 1978. His exceptional insights into the business of health care have helped guide OP’s practice management coverage during the past 10 years.

Ms. Williams is the president of BSM Consulting. She is responsible for all BSM operations, including setting strategic initiatives, overseeing operations, facilitating staff development, and facilitating strategic partner and vendor relations. Prior to joining BSM in 2018, Ms. Williams worked for 25 years in pharmaceutical sales and marketing, holding both management and senior leadership positions. She became an iPEC certified professional coach in 2018. OP

In Brief

The FDA approved Bausch + Lomb’s ClearVisc ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery. ClearVisc helps provide physical protection of the cornea from thermal and mechanical damage. It also contains Sorbitol, which is a unique chemical agent that has been shown in a laboratory study to deliver superior free radical protection compared to other dispersive OVDs.

OASIS Medical Inc. launched its new cyber platform, MY OASIS. MY OASIS is a cyber platform for eye-care providers that can offer insights into a practice’s monthly flow of OTC solutions and their compounding community expansion. MY OASIS can be used by practices as a storefront for OASIS products. The MY OASIS platform is available on Apple’s iOS App Store and Android’s Google Play store.

Regeneron announced results of the Phase 3, NIH-sponsored Protocol W trial have been published in JAMA Ophthalmology. In the trial, Eylea (aflibercept) reduced the risk of vision-threatening complications by 68% after 2 years when used in diabetic retinopathy patients. Patients receiving sham injections were almost five times more likely to require Eylea rescue therapy.

Sight Sciences received 510(k) clearance from the FDA for its OMNI Surgical System for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce IOP in adult patients with primary open-angle glaucoma.

OCULUS received 510(k) clearance from the FDA for its Pentacam AXL Wave with optical biometry, retroillumination, objective refraction, and wavefront aberrometry. The Pentacam AXL Wave incorporates reports based on clinical studies with guaranteed network compatibility and full operability of all Pentacam software and examinations.

The American Academy of Ophthalmology urged ophthalmic imaging device manufacturers to standardize image formats to comply with the Digital Imaging and Communications in Medicine (DICOM) standard, the medical imaging standard recognized throughout the world. Widespread adoption of the standard can help promote more efficient patient care, enabling the creation of comprehensive datasets for research and big data analyses and developing algorithms for machine learning and artificial intelligence, according to an AAO statement.

What to Read Next